India
· Delayed Price · Currency is INR NSE:SUNPHARMA Statistics
Total Valuation
NSE:SUNPHARMA has a market cap or net worth of INR 4.01 trillion. The enterprise value is 3.78 trillion.
| Market Cap | 4.01T |
| Enterprise Value | 3.78T |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | Jul 7, 2025 |
Share Statistics
NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 2.40B |
| Shares Outstanding | 2.40B |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | 12.01% |
| Owned by Institutions (%) | 28.61% |
| Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 36.61 and the forward PE ratio is 32.12. NSE:SUNPHARMA's PEG ratio is 2.26.
| PE Ratio | 36.61 |
| Forward PE | 32.12 |
| PS Ratio | 7.62 |
| PB Ratio | 5.53 |
| P/TBV Ratio | 7.38 |
| P/FCF Ratio | 33.54 |
| P/OCF Ratio | 28.47 |
| PEG Ratio | 2.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 25.10, with an EV/FCF ratio of 31.67.
| EV / Earnings | 34.61 |
| EV / Sales | 7.19 |
| EV / EBITDA | 25.10 |
| EV / EBIT | 30.27 |
| EV / FCF | 31.67 |
Financial Position
The company has a current ratio of 2.89, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.89 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.20 |
| Interest Coverage | 54.07 |
Financial Efficiency
Return on equity (ROE) is 15.71% and return on invested capital (ROIC) is 10.77%.
| Return on Equity (ROE) | 15.71% |
| Return on Assets (ROA) | 8.81% |
| Return on Invested Capital (ROIC) | 10.77% |
| Return on Capital Employed (ROCE) | 16.93% |
| Revenue Per Employee | 12.23M |
| Profits Per Employee | 2.54M |
| Employee Count | 43,000 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 1.05 |
Taxes
In the past 12 months, NSE:SUNPHARMA has paid 27.72 billion in taxes.
| Income Tax | 27.72B |
| Effective Tax Rate | 20.18% |
Stock Price Statistics
The stock price has increased by +11.72% in the last 52 weeks. The beta is 0.38, so NSE:SUNPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +11.72% |
| 50-Day Moving Average | 1,718.66 |
| 200-Day Moving Average | 1,770.84 |
| Relative Strength Index (RSI) | 45.18 |
| Average Volume (20 Days) | 2,362,074 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUNPHARMA had revenue of INR 525.78 billion and earned 109.29 billion in profits. Earnings per share was 45.60.
| Revenue | 525.78B |
| Gross Profit | 418.31B |
| Operating Income | 125.11B |
| Pretax Income | 137.37B |
| Net Income | 109.29B |
| EBITDA | 150.86B |
| EBIT | 125.11B |
| Earnings Per Share (EPS) | 45.60 |
Balance Sheet
The company has 249.88 billion in cash and 23.62 billion in debt, giving a net cash position of 226.26 billion or 94.30 per share.
| Cash & Cash Equivalents | 249.88B |
| Total Debt | 23.62B |
| Net Cash | 226.26B |
| Net Cash Per Share | 94.30 |
| Equity (Book Value) | 724.86B |
| Book Value Per Share | 302.32 |
| Working Capital | 344.30B |
Cash Flow
In the last 12 months, operating cash flow was 140.72 billion and capital expenditures -21.29 billion, giving a free cash flow of 119.44 billion.
| Operating Cash Flow | 140.72B |
| Capital Expenditures | -21.29B |
| Free Cash Flow | 119.44B |
| FCF Per Share | 49.78 |
Margins
Gross margin is 79.56%, with operating and profit margins of 23.79% and 20.79%.
| Gross Margin | 79.56% |
| Operating Margin | 23.79% |
| Pretax Margin | 26.13% |
| Profit Margin | 20.79% |
| EBITDA Margin | 28.69% |
| EBIT Margin | 23.79% |
| FCF Margin | 22.72% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | 18.52% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 33.07% |
| Buyback Yield | 0.11% |
| Shareholder Yield | 1.07% |
| Earnings Yield | 2.73% |
| FCF Yield | 2.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |